Medicine in Uzbekistan can make progress in the future, Indian Taj Pharmaceuticals’ CEO Dr. Ranvir Singh told Trend in an interview. Dr. Singh stressed that as far as pharmaceutical manufacturing is concerned, Uzbekistan is far from having established production of complex pharma products. “The state has local manufacturing; however, complex products are yet far from
Chairman of Indian Company Taj Pharmaceuticals, Dr. Ranvir Singh spoke to Trend in an interview about the development of medicine in Uzbekistan, the Indian-Uzbek Free Pharmaceutical Zone and more. “The primary advantage is location where our manufacturing unit will be established in Indian-Uzbek Free Pharmaceutical Zone. The core advantages are: First of all, location is
Attract prime talent in pharma market. Develop highly professional talent Retain top talent with unique accountability. Winning through innovation. Winning the right way Deliver value to shareholders and patients Lean Cost Base (Resources Sharing). Therapeutic Area Leadership through Targeted Growth Opportunities Agile Customer Centric go to market approach.